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Pyeloureteric magnetic anastomosis device to simplify
laparoscopic pyeloplasty: a proof-of-concept study
Laparoscopic pyeloplasty is a standard, but demanding
operation. According to the European Association of Urology
guidelines this procedure scores 13 out of 18 on the difficulty
scale [1]. Articulating instruments, three-dimensional video
systems and robots may facilitate complex suturing of the
ureteropelvic anastomosis at higher financial costs [2,3].
Magnetic compression anastomosis (magnamosis) has been
used safely and effectively in the gastrointestinal tract [4,5];
however, it has not been applied in the urinary tract.
The aim of the present study was to prove the concept of
magnamosis in the urinary system and to develop a
pyeloureteric magnetic anastomosis (PUMA) device in order
to simplify laparoscopic pyeloplasty.
The study was conducted using a stepwise approach [6] in six
female Vietnamese minipigs, in accordance with the National
Institutes of Health guidelines and European Union directive
2010/63 for the protection of animals used for scientific
purposes, and was approved by the National Scientific Ethical
Committee (V.2480/2017). In order to perform the procedure
laparoscopically throughout, a hydronephrosis model [7] was
finally applied in animals 5 and 6 (Table 1).
In all cases, N35 neodymium nickel-coated magnetic cylinders
with a 4-mm outer diameter, 2-mm inner diameter and 8-mm
length were applied to a 4.8-Fr, 22-cm long JJ stent or a 4.7-Fr,
12- to 18-cm pyeloureteric stent (Salle stent). The ‘ureteric’
magnet was fixed to the stent. The ‘pelvic’ magnets were left
unattached in animals 1 and 2, but inserted/fixed into a 10-Fr
‘nephrostomy’ tube (animals 3 and 4) or into a Malecot
catheter tip (animals 5 and 6), respectively. A surgical needle
(31 mm ½ c tapered) was integrated into the proximal end of
the stents using cyanoacrylate glue.
The stents with the ‘ureteric’ magnet were threaded into the
ureter and/or the bladder. The proximal part of the stents
with the integrated needle was stitched inside-out from the
ureter 10 mm below the free end, which was closed with a 5-
mm titanium clip (Video S1).
The stents were stitched into the ‘pelvis’ in an outside-inside
fashion. The ‘pelvic’ magnet was threaded onto the stents. In
animals 1, 5 and 6, JJ stents, and in animals 2 to 4, Salle
stents were applied, with the proximal tip being brought out
as a ‘nephrostomy’ via a 10-Fr suction catheter in the latter.
The ‘pelvis’ was closed with a 4/0 barbed suture
(Polydioxanone, synthetic monofilament absorbable barbed
suture) without the need for knot tying (Video S1).
Because each intervention required another anaesthesia,
postoperative imaging was kept to a minimum. The animals
were killed between 2 (animal 1) and 10 weeks (animal 6)
after the procedure, and the anastomoses were assessed
macroscopically and/or microscopically, using haematoxylin
and eosin staining. The magnets were removed via the vesico-
ureteric junction in animals 1 and 5 at autopsy. In animal 6
the PUMA was removed via cystoscopy in vivo 4 weeks prior
to termination (Table 1).
A PUJ obstruction model, made from a spherical birthday
balloon (40 mm, representing the dilated pelvis) and a
sausage balloon (5 mm, representing the proximal ureter),
was placed on a laparoscopic simulator (Eosurgical Ltd,
Edinburgh, UK). Eleven surgeons, experienced in laparoscopy,
were asked to perform a laparoscopic ureteropelvic
anastomosis using the standard approach followed by using
the PUMA device. The time required for the procedures was
recorded. The quality of the performance was assessed by the
instructor (T.C.) as well as the candidates, and rated with
scores ranging from 1 (poor) to 5 (excellent). Subsequently, a
time–quality score was calculated using the formula:
time–quality score = time × 5/quality score.
After initial failure in animals 1 and 2, a widely patent
anastomosis was achieved in animals 3 to 6. After having
switched to the hydronephrotic animal model, the procedure
was carried out laparoscopically throughout. The need for
laparoscopic suturing and knot-tying was eliminated. Removal
of the magnetic JJ stent was possible via the vesico-ureteric
junction (Table 1). The anastomosis remained widely patent
after removal of the device.
In the simulation, the mean time required for the
anastomosis dropped from 39.91  14.08 to 8.18  2.75 min
(P < 0.0001) and the quality increased from a median (range)
of 3 (2–5) to a median (range) of 5 (3–5) with the PUMA
device (P = 0.0156). The mean time–quality score was
significantly higher (i.e. less favourable) with the standard
technique (67.79  34.42) compared with the PUMA method
(9.45  5.14; P = 0.0003). Of note, in each case the time
taken for the procedure was shorter and the estimated quality
either better or equivalent with the PUMA device.
The ideal magnetic compression force to create a ureteric
anastomosis is unknown. A recent experimental study
estimated the optimal pressure to be between 79.8 and
169 kPa for an intestinal anastomosis in dogs [8]. The
maximal magnetic compression force of the magnets that
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were applied in this study lies between 3 and 4 N, as stated
by the manufacturer (Euromagnet KFT, Budapest, Hungary).
It is well known that the magnetic force is inversely
proportional to the square of the distance between the
magnets. In order to calculate the magnetic pressure, we
considered a 2-mm separation (i.e. two times the ureteric wall
thickness) of the magnets since the normal ureteric wall
thickness has been estimated to be approximately 1 mm.
Subsequently, the area of the magnets was calculated using
the equation:





Therefore, the magnetic pressure in our study ranged between
79.6 and 106.1 kPa, calculated by: Pressure¼ 0:25∗ ForceAreaðsurfaceÞ.
These numbers were in accordance with the above-mentioned
study [8].
In the present series, postoperative X-rays revealed that the
magnets did not cut through very rapidly, providing a
reasonable time (i.e. 7 days) for the ureteric wall to remodel
and heal. Moreover, no extravasation of contrast was seen on
intravenous urography. We observed a narrowing of the
anastomosis only in animals 1 and 2, in which the magnets
passed below and only a small-calibre stent was present at the
PUJ 14 days after the procedure. However, good-sized
anastomosis was achieved in those animals in which the
magnets or large-calibre stent remained at the level of the
PUJ for at least 14 days. This may indicate that the
anastomosis has to be kept open at a full calibre for a few
weeks to prevent stricture. Of note, in animal 6 no narrowing
was observed 4 weeks after stent removal.
The simulation revealed a significantly shorter operating time
with the PUMA device compared with the standard method.
The quality of the new operation (i.e. position and adherence
of the magnets) was rated as being equivalent or superior in
each case. Moreover, all participants found the new technique
less demanding. In addition, although not in accordance with
our original study protocol, we asked five paediatric nurses,
who had never received training in laparoscopic
instrumentation, to perform an anastomosis with the PUMA
device in the simulator after watching a short tutorial video.
Interestingly, their average time to complete the task was only
slightly longer compared with that of the surgeons (10.60 
1.67 vs 8.18  2.75 min).
This was a proof-of-concept study and has its limitations. A
limited number of animals were used, and only short-term
follow-up was applied to prove a patent anastomosis.
In summary, magnamosis has great potential in creating a
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Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Video S1. Pyeloplasty wth the PUMA device (https://www.d
ropbox.com/s/wf70aknoh561v9u/Video-Puma2.mp4?dl=0).
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